The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Artificial intelligence (AI) –powered H&E whole-slide image (WSI) analysis of tertiary lymphoid structure (TLS) correlates with immune phenotype and related molecular signatures in non–small-cell lung cancer.
 
Sanghoon Song
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Wonkyung Jung
Employment - Lunit
 
Soo Ick Cho
Employment - Lunit
Stock and Other Ownership Interests - Lunit
Consulting or Advisory Role - ArtLab
 
Juneyoung Ro
Employment - Lunit
 
Hajin Lee
Employment - Lunit
 
Minuk Ma
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Seonwook Park
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Donggeun Yoo
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit
Patents, Royalties, Other Intellectual Property - Lunit
 
Leeseul Kim
No Relationships to Disclose
 
Liam Il-Young Chung
No Relationships to Disclose
 
Young Kwang Chae
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Foundation Medicine; Guardant Health; Immuneoncia; Lilly; Lunit; Roche/Genentech; Takeda; Tempus
Speakers' Bureau - AstraZeneca; BMS; G1 Therapeutics; Genentech/Roche; Jazz Pharmaceuticals; Lilly; Merck
Research Funding - Abbvie; Biodesix; Bristol-Myers Squibb; Freenome; Lexent Bio
 
Chan-Young Ock
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit; Medpacto; Y-Biologics
Consulting or Advisory Role - Genome & Company; Idience; Medpacto; PIN therapeutics; Selecxine; Y-Biologics